We have US and EU patents for the treatment of IBS-d and will begin a Phase II clinical trial with interest from 6 pharma companies
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free